pLEX-HA-birA*-K-Ras(G12D)-IRES-Puro Citations (3)

Originally described in: The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.
Kovalski JR, Bhaduri A, Zehnder AM, Neela PH, Che Y, Wozniak GG, Khavari PA Mol Cell. 2019 Jan 4. pii: S1097-2765(18)31031-1. doi: 10.1016/j.molcel.2018.12.001. PubMed Journal

---

Articles Citing pLEX-HA-birA*-K-Ras(G12D)-IRES-Puro

Articles
Targeting eIF4A Dependent Translation of KRAS Signaling Molecules. Singh K, Lin J, Lecomte N, Mohan P, Gokce A, Sanghvi VR, Jiang M, Grbovic-Huezo O, Burcul A, Stark SG, Romesser PB, Chang Q, Melchor JP, Beyer RK, Duggan M, Fukase Y, Yang G, Ouerfelli O, Viale A, de Stanchina E, Stamford AW, Meinke PT, Ratsch G, Leach SD, Ouyang Z, Wendel HG. Cancer Res. 2021 Feb 25. pii: 0008-5472.CAN-20-2929. doi: 10.1158/0008-5472.CAN-20-2929. PubMed
An extracellular vesicular mutant KRAS-associated protein complex promotes lung inflammation and tumor growth. Sriwastva MK, Teng Y, Mu J, Xu F, Kumar A, Sundaram K, Malhotra RK, Xu Q, Hood JL, Zhang L, Yan J, Merchant ML, Park JW, Dryden GW, Egilmez NK, Zhang HG. J Extracell Vesicles. 2023 Feb;12(2):e12307. doi: 10.1002/jev2.12307. PubMed
Mutant KRAS-driven selective mRNA translation reveals mechanisms and therapeutic vulnerabilities in cancer. Shrivastava A, Pederson EN, Nguyen TU, Chuen J, Mohan P, Pande S, Toribio AR, Lecomte N, Melchor J, McAuliffe JC, Grandgenett PM, Rajasekhar VK, Nishikawa K, Knorlein A, David Y, Willis IM, Iacobuzio-Donahue CA, Ouyang Z, Singh K. Cell Rep. 2026 Jun 23;45(6):117520. doi: 10.1016/j.celrep.2026.117520. Epub 2026 Jun 12. PubMed

If you have published an article using this material, please email us at to have your article added to this page.